Clinical Trials Directory

Trials / Completed

CompletedNCT02839473

Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial

Hydrosorb® Versus Control (Water Based Spray) in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
278 (actual)
Sponsor
Institut Curie · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective consisted of avoiding deterioration and/or restoring the integrity of the skin of patients treated by radiotherapy, right from the first signs of grade 1 or 2 radiation dermatitis.

Conditions

Interventions

TypeNameDescription
DEVICECastalie water spray
DEVICEHydrogel Hydrosorb®

Timeline

Start date
2010-03-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2016-07-21
Last updated
2025-09-19

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02839473. Inclusion in this directory is not an endorsement.

Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized (NCT02839473) · Clinical Trials Directory